Mexalen Rapid

Paracetamol, the active ingredient in Mexelen Rapid, is an analgesic presented as an oral formulation for oral use. It is commonly employed to reduce fever and relieve mild to moderate pain in adults and children. Its rapid‑acting profile makes it suitable for prompt symptom control in febrile episodes and headache, toothache, or musculoskeletal discomfort.

GNH USA supplies Mexelen Rapid as a licensed, GDP‑compliant international pharmaceutical product to hospitals, pharmacies, clinics and procurement teams worldwide.

Paracetamol acts centrally to lower fever and alleviate pain, making it useful for several common conditions.

Fever: reduces elevated body temperature Headache: relieves tension‑type and mild migraine pain Toothache: eases dental pain after procedures Musculoskeletal pain: mitigates aches from strains or minor injuries

Paracetamol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea - Abdominal discomfort - Rash or mild skin irritation - Headache - Dizziness - Transient elevation of liver enzymes

Serious or Rare Side Effects: - Severe skin reactions such as Stevens‑Johnson syndrome - Acute liver failure, especially with overdose - Blood dyscrasias including thrombocytopenia - Anaphylaxis or severe allergic reactions - Hepatic necrosis in patients with pre‑existing liver disease - Renal impairment in susceptible individuals

When using Mexelen Rapid, consider the following precautions.

Assess liver function: avoid in patients with severe hepatic impairment Avoid exceeding recommended total daily dose: adhere to label limits Use caution with alcohol: increased risk of liver toxicity Consult a healthcare professional before use in children: dosing varies by age Pregnancy and breastfeeding: discuss with a provider before use Store at ambient temperature: keep in the original pack, protect from moisture.

Paracetamol may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Warfarin: may increase bleeding risk - Alcohol: heightened potential for liver injury - Carbamazepine: may reduce analgesic efficacy - Isoniazid: increased risk of hepatotoxicity

Moderate Interactions (Monitor Closely): - Phenytoin: enzyme induction may lower paracetamol levels - Rifampicin: may increase metabolism, reducing effectiveness - Oral contraceptives: may elevate liver enzyme activity, requiring monitoring